Is GHRP-6 safe?
Only single-dose data
CAnimal and cell studiesNot approvedas of 2026-10-26
The 34-hour infusion study reported no serious adverse effects. Thyroid-stimulating hormone was lower during the infusion. The peptide mimics ghrelin, so more hunger is expected. Users report it with GHRP-6 in particular. No one has studied long-term safety in humans. Growth hormone raises blood glucose and IGF-1. So the theoretical concerns are insulin resistance and growth of existing tumours. Research-chemical products carry no purity assurance. 32
More on GHRP-6
Citations
- Bodart 2002, Circulation Research: CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart doi.org
- Jaffe 1993, Journal of Clinical Endocrinology and Metabolism: prolonged GHRP-6 infusion and pulsatile growth hormone secretion in normal men doi.org
- Cao 2006, Trends in Endocrinology and Metabolism: effects of ghrelin and synthetic GH secretagogues on the cardiovascular system doi.org
Reference information only, not medical advice. Drawn from the GHRP-6 article, fact-checked against the cited sources. No dosing anywhere on this site.